Mirae Asset Global Investments
ACRS icon

Mirae Asset Global Investments’s Aclaris Therapeutics ACRS Stock Holding History

Mirae Asset Global Investments’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Sell
6,246
-44
-0.7% -$196 ﹤0.01% 1420
2026
Q1 		$23.6K Buy
6,290
+1,025
+19% +$3.46K ﹤0.01% 1411
2025
Q4 		$15.8K Buy
+5,265
New +$13.3K ﹤0.01% 1558
2024
Q4 		– Sell
-2,580
Closed -$3.02K – 1593
2024
Q3 		$3.02K Buy
2,580
+452
+21% +$554 ﹤0.01% 1533
2024
Q2 		$2.36K Sell
2,128
-29,424
-93% -$34.6K ﹤0.01% 1506
2024
Q1 		$239K Buy
+31,552
New +$37.6K ﹤0.01% 2194
2023
Q4 		– Sell
-32,807
Closed -$225K – 2521
2023
Q3 		$225K Buy
32,807
+1,762
+6% +$15.1K ﹤0.01% 2248
2023
Q2 		$322K Sell
31,045
-47
-0.2% -$425 ﹤0.01% 2155
2023
Q1 		$252K Sell
31,092
-43
-0.1% -$546 ﹤0.01% 2247
2022
Q4 		$490K Buy
31,135
+4,423
+17% +$71.2K ﹤0.01% 1903
2022
Q3 		$420K Buy
26,712
+10,467
+64% +$165K ﹤0.01% 1975
2022
Q2 		$227K Buy
+16,245
New +$228K ﹤0.01% 2103

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TBWA
Three Bridge Wealth Advisors Los Altos, California $399M AUM 18.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mirae Asset Global Investments's ACRS Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Aclaris Therapeutics (ACRS) stake by 0.7% in Q2 2026, selling an estimated $196 and leaving 6,246 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Mirae Asset Global Investments first reported a position in ACRS in Q2 2022 and has held it in 12 quarters since. The position peaked at $490K in Q4 2022. 44 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Mirae Asset Global Investments held 6,246 shares of Aclaris Therapeutics worth $33K as of Q2 2026.
  • Mirae Asset Global Investments sold 44 Aclaris Therapeutics shares in Q2 2026, an estimated $196.
  • Aclaris Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1420 holding.
  • Mirae Asset Global Investments first reported a position in Aclaris Therapeutics in Q2 2022 and has held it in 12 quarters since.
  • Mirae Asset Global Investments's Aclaris Therapeutics position peaked at $490K in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.